Synapse Biomedical Inc.
Harrisburg, US · Delaware corporation · 1 known investors
Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS. The company serves clinicians and patients dependent on mechanical ventilation.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
AR
Anthony R IgnagniExecutive Officer, Director
KM
Kiyotaka MoriDirector
MD
Moustapha DiopChief Operating Officer
RP
Raymond P OndersDirector
JK
John KrystowskiDirector
AR
Anthony R. IgnagniCo-founder, President & CEO
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$810KofferedDec 2022 · BiotechnologyRule 506(b)
▶$810KofferedDec 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony R IgnagniExecutive Officer, Director
- Kiyotaka MoriDirector
- Moustapha DiopExecutive Officer, Director
- Raymond P OndersDirector
- John KrystowskiDirector
- Offering amount
- $810K
- Minimum investment
- $1.5K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.